RCE 3.67% 56.5¢ recce pharmaceuticals ltd

Ann: Positive Patients Update - Special Access Scheme, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,376 Posts.
    lightbulb Created with Sketch. 692
    Great find zecs.
    They have known this since 1/12/22 it seems. It would be interesting to know why they would have trouble recruiting participants if they had multiple drug resistant infections. I would surely assume it is because of discomfort or pain on application.
    at least we know there was a problem and no big secret of it working but holding the information. I guess it just confirms what will happen if there are any issues with uti or other trials. On the positive side now looking VERY good for the foot ulcer trials.
    Recruitment
    Recruitment status
    Stopped early
    Data analysis
    Data analysis is complete
    Reason for early stopping/withdrawal
    Participant recruitment difficulties
    Date of first participant enrolment
    Anticipated
    Actual


    Date of last participant enrolment
    Anticipated
    Actual

    Date of last data collection
    Anticipated
    Actual

    Sample size
    Target
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.